| 标题 |
Biomarker Driven Phase II Clinical Trial of Trametinib in Relapsed/Refractory Multiple Myeloma with Sequential Addition of the AKT Inhibitor, GSK2141795 at Time of Disease Progression to Overcome Treatment Failure: A Trial of the Princess Margaret Phase II Consortium |
| 网址 | |
| DOI |
10.1182/blood.v128.22.4526.4526
doi
|
| 其它 |
期刊:Blood 作者:Suzanne Trudel; Nizar J. Bahlis; Christopher P. Venner; Annette E Hay; Olena Kis; et al 出版日期:2016-12-02 |
| 求助人 | |
| 下载 | 暂无链接,等待应助者上传 |
PDF的下载单位、IP信息已删除
(2025-6-4)